Immunotherapy in non-small cell lung cancer: advancements and challenges

Immunotherapy in non-small cell lung cancer: advancements and challenges

Bibliographic Details
Main Authors:	Fei Zhou, Cai-Cun Zhou, Pei-Fang Wei
Format:	Article
Language:	English
Published:	Wolters Kluwer 2021-05-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000001338

Similar Items

Combination strategies of immunotherapy in non-small cell lung cancer: facts and challenges
by: Chu-Ling Li, et al.
Published: (2021-08-01)

Advances in Immunotherapies for Non-small Cell Lung Cancer
by: Yuan HE, et al.
Published: (2014-03-01)

First-line Combination Immunotherapy in Advanced Non-small Cell Lung Cancer
by: Xiaoxiao PENG, et al.
Published: (2018-12-01)

Developments in Immunotherapy for Advanced Non-small Cell Lung Cancer
by: Haoyang LI, et al.
Published: (2021-02-01)

Immunotherapy Advances in Small Cell Lung Cancer
by: Yangyang XU, et al.
Published: (2020-11-01)

Advances of Immunotherapy in Small Cell Lung Cancer
by: Jingjing LIU, et al.
Published: (2014-06-01)

Potential role of immunotherapy in advanced non-small-cell lung cancer
by: de Mello RA, et al.
Published: (2016-12-01)

Research Progress of Immunotherapy for Advanced Non-small Cell Lung Cancer
by: CHENG Ying
Published: (2021-08-01)

Advances and Challenges of Local Thermal Ablation in Non-small Cell Lung Cancer
by: Qing GOU, et al.
Published: (2020-02-01)

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
by: Lorenza Landi, et al.
Published: (2019-11-01)

Advances of the Correlation between Driver Gene Status and Immunotherapy  in Non-small Cell Lung Cancer
by: Jie CHEN, et al.
Published: (2019-04-01)

Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing
by: Jingsi Dong, et al.
Published: (2019-03-01)

Advances in Hyperprogressive Disease in Patients  with Advanced Non-small Cell Lung Cancer Treated with Immunotherapy
by: Shuyang YAO, et al.
Published: (2021-04-01)

Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
by: Irene Moya-Horno, et al.
Published: (2018-01-01)

Toxicities of Immunotherapy for Small Cell Lung Cancer
by: Yang Fu, et al.
Published: (2021-05-01)

Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker
by: Chang Chen, et al.
Published: (2020-07-01)

Progress in Immunotherapy for Non-small Cell Lung Cancer
by: Yan XU, et al.
Published: (2014-01-01)

Imaging Biomarkers to Predict and Evaluate the Effectiveness of Immunotherapy in Advanced Non-Small-Cell Lung Cancer
by: Ying Liu, et al.
Published: (2021-03-01)

Advances on micrometastasis of Non-small Cell Lung Cancer
by: Mingming BI, et al.
Published: (2009-09-01)

The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer
by: Jingjing Qu, et al.
Published: (2021-02-01)

Immunotherapy rechallenge in patients with non-small-cell lung cancer
by: S. España, et al.
Published: (2020-07-01)

First Line Immunotherapy for Non-Small Cell Lung Cancer
by: Nicola J. Nasser, et al.
Published: (2020-11-01)

Management of Non-Small Cell Lung Cancer: The Era of Immunotherapy
by: Tiziana Vavalà
Published: (2018-06-01)

PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY
by: A. V. Rudakova, et al.
Published: (2017-08-01)

Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer
by: Shouzheng WANG, et al.
Published: (2016-10-01)

Immunotherapy in Small Cell Lung Cancer
by: Antonio Rossi
Published: (2019-06-01)

Immunotherapy in Small Cell Lung Cancer
by: Giovanna Esposito, et al.
Published: (2020-09-01)

Immunotherapy for small-cell lung cancer
by: A. Ye. Kuzminov, et al.
Published: (2019-06-01)

Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer  with Brain Metastasis
by: Qi SONG, et al.
Published: (2016-08-01)

Indirect comparison between immunotherapy alone and immunotherapy plus chemotherapy as first-line treatment for advanced non-small cell lung cancer: a systematic review
by: Fei Xu, et al.
Published: (2020-11-01)

Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer
by: Qi Xiong, et al.
Published: (2021-07-01)

Comparative Efficacy and Safety of Immunotherapy Alone and in Combination With Chemotherapy for Advanced Non-small Cell Lung Cancer
by: Xue Wang, et al.
Published: (2021-03-01)

Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer
by: Liang H, et al.
Published: (2019-08-01)

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
by: Valente Nancy, et al.
Published: (2005-02-01)

Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer
by: Bomba, A., et al.
Published: (2022)

Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non‐small cell lung cancer
by: Qian Zhao, et al.
Published: (2021-09-01)

Soluble Biomarkers with Prognostic and Predictive Value in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy
by: Beatriz Honrubia-Peris, et al.
Published: (2021-08-01)

Cost-effectiveness of Immunotherapy for Locally Advanced or Metastatic Non-small Cell Lung Cancer after Chemotherapy
by: Chih-Wen Chang, et al.
Published: (2019)

Peripheral Blood Inflammation Indicators as Predictive Indicators in  Immunotherapy of Advanced Non-small Cell Lung Cancer
by: Jingwei XIA, et al.
Published: (2021-09-01)

Immunotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: Clinical Challenges and Future Directions
by: Ranjan Pathak, et al.
Published: (2021-07-01)